Policy, Law, Economics and Politics - Deepening Democracy through Access to Information
This privately-owned website is operated and maintained by Creamer Media
We have detected that the browser you are using is no longer supported. As a result, some content may not display correctly.
We suggest that you upgrade to the latest version of any of the following browsers:
         
close notification
23 May 2012
   
 
 
 
 
 
Caug ht between its allies in the drug industry and its promises to battle Aids in Africa, the administration of US President George W Bush is facing mounting pressure to allow its multibillion-dollar Aids fund to spend money on generic combination drugs in Africa, reports The Wall Street Journal Europe.

The generic drugs cost a fourth as much as their name-brand counterparts, a price that would make them available to many more of the 30-million Africans with Aids.

They are being pushed hard by the WHO and various Aids activist groups. But makers of brand-name pharmaceuticals, already fighting a global flood of attempts to copy their patented treatments, strongly oppose their use –in part, they say, for safety reasons.

Edited by: laurian clemence
 
 
 
 
 
  Map
 
 
 
 
 
 
 
Advertisements:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Topics on this page
 
 
 
Continent
 
Africa
Country
 
united states
Organisation
 
Aids
World Health Organization
Person
 
george w bush
Published Medium
 
The Wall Street Journal Europe
 
 
 
 
 
 
Online Publishers Association